Markets:

Overview

News

Currencies

International

Treasuries

Kezar Life Sciences, Inc. - Common Stock (NQ:KZR)

6.340 +0.020 (+0.32%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kezar Life Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 04, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...

Via Benzinga

Mid-Day Market Update: Dow Rises 100 Points; Lyft Shares Plummet ↗

May 04, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Wednesday.

Via Benzinga

Kezar Life's Lead Asset Fails To Top Placebo In Muscle Inflammation Disease ↗

May 04, 2022

Via Benzinga

Why Kezar Life Sciences Shares Are Getting Hammered ↗

May 04, 2022

Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading lower by 38.23% at $7.61 after the company announced top-line results from its PRESIDIO Phase 2 clinical trial of...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points ↗

May 04, 2022

U.S. stocks traded mixed this morning, with the Nasdaq dropping more than 100 points on Wednesday.

Via Benzinga

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗

May 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 04, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis

May 03, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

April 15, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC) ↗

March 28, 2022

Via Benzinga

58 Biggest Movers From Yesterday ↗

March 24, 2022

Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

March 23, 2022

Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...

Via Benzinga

Here's Why Kezar Life Sciences Shares Are Moving ↗

March 18, 2022

Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading higher by 5.0% at $16.08 after HC Wainwright & Co. maintained a Buy rating on the stock and raised its price target...

Via Benzinga

Kezar Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update

March 17, 2022

From Kezar Life Sciences, Inc.

Via Business Wire

Kezar Appoints Courtney Wallace to its Board of Directors

December 10, 2021

From Kezar Life Sciences

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗

December 08, 2021

Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...

Via Benzinga

80 Biggest Movers From Yesterday ↗

November 17, 2021

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide ↗

November 16, 2021

Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,239.46 while the NASDAQ rose 0.76% to 15,974.21. The S&P also rose, gaining 0.59% to 4,710.24. The U.S. has...

Via Benzinga

Topics Stocks

Stocks Rise Amid Upbeat Consumer Strength Data ↗

November 16, 2021

The Dow Jones Industrial Average is extending this morning's gains, up 189 points at last check, while the S&P 500 and Nasdaq Composite are also in the black midday.

Via Talk Markets

Topics Stocks

Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge ↗

November 16, 2021

Midway through trading Tuesday, the Dow traded up 0.25% to 36,176.74 while the NASDAQ rose 0.19% to 15,883.75. The S&P also rose, gaining 0.21% to 4,692.49. The U.S. has the...

Via Benzinga

Topics Stocks

Why Kezar Life Sciences Stock Is Soaring Today ↗

November 16, 2021

The company reported promising results from a phase 2 study.

Via The Motley Fool

53 Stocks Moving In Tuesday's Mid-Day Session ↗

November 16, 2021

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations ↗

November 16, 2021

Following the market opening Tuesday, the Dow traded up 0.40% to 36,231.05 while the NASDAQ rose 0.20% to 15,885.76. The S&P also rose, gaining 0.31% to 4,697.11. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 16, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...

Via Benzinga

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗

November 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 16, 2021

Good morning, trader! Start your day off the right way with a breakdown of the biggest pre-market stock movers for Tuesday.

Via InvestorPlace

36 Stocks Moving in Tuesday's Pre-Market Session ↗

November 16, 2021

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ:...

Via Benzinga

Small-cap Biopharma Kezar Life Sciences Is Soaring, Here's Why ↗

November 16, 2021

Kezar Life Sciences, Inc. (NASDAQ: KZR) shares are soaring Tuesday following a positive clinical readout. What Happened: California-based Kezar announced...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 15, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) s...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Kezar Life Sciences, Inc. - Common Stock (NQ:KZR)

All News about Kezar Life Sciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today